--------------------------------------------------------------------------------
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB
[X]      QUARTERLY  REPORT  PURSUANT  TO SECTION  13 OR 15(d) OF THE  SECURITIES
         EXCHANGE ACT OF 1934

                For the Quarterly Period Ended September 30, 2004

                                       or

[ ]      TRANSITION  REPORT  PURSUANT  TO SECTION 13 OR 15(d) OF THE  SECURITIES
         EXCHANGE ACT OF 1934

                          Commission File Number 28541

                           QUINTEK TECHNOLOGIES, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


        California                                            77-0505346
---------------------------------                          --------------------
(State or other jurisdiction                               (I.R.S. Employer
of incorporation or organization)                         Identification No.)

                               17951 Lyons Circle
                           Huntington Beach, CA 92647
                    ----------------------------------------
                    (Address of principal executive offices)


                   Registrant's telephone number: 714-848-7741

Check whether the registrant  (1) has filed all reports  required to be filed by
Section 13 or 15(d) of the Securities  Exchange Act of 1934 during the preceding
12 months (or for such shorter  period that the  registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days.     Yes [X]   No [ ]

                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check whether the registrant has filed all documents and reports  required to be
filed by Section 12,13,  or 15(d) of the  Securities  Exchange Act of 1934 after
the distribution of securities under a plan confirmed by a court. Yes[ ]  No[ ]

                      APPLICABLE ONLY TO CORPORATE ISSUERS

At September 30, 2004, a total of 71,122,454 shares of registrant's Common Stock
were outstanding.

Transitional Small Business Disclosure Format: Yes [ ] No [X]



<PAGE>



TABLE OF CONTENTS

PART I           FINANCIAL INFORMATION
Item 1.          Financial Statements
                    Balance Sheets
                    Statement of Operations
                    Statements of Cashflows
                    Notes to Financial Statements
Item 2.          Management's Discussion and Analysis
Item 3.          Controls and Procedures

PART II          OTHER INFORMATION
Item 1.          Legal Proceedings
Item 2.          Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.          Defaults Upon Senior Securities
Item 4.          Submission of Matters to a Vote of Security Holders
Item 5.          Other Information
Item 6.          Exhibits
Signatures
Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2


                                       2



<PAGE>



                                      Index

PART I       FINANCIAL INFORMATION                                         4
Item 1       Financial Statements                                          4
Item 2       Management's Discussion and Analysis                         24
Item 3       Disclosure Controls and Procedures                           25

PART II      OTHER INFORMATION                                            25
Item 1       Legal Proceedings                                            25
Item 2       Changes in Securities                                        25
Item 3       Defaults Upon Senior Securities                              27
Item 4       Submission of Matters to a Vote of Security Holders          27
Item 5       Other Information                                            27
Item 6       Exhibits and Reports on Form 8-K                             27
Signatures                                                                28



                                       3
<PAGE>

                         PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

<TABLE>
<CAPTION>
                             QUINTEK TECHNOLOGIES, INC.
                                 BALANCE SHEET
                               SEPTEMBER 30, 2004
                                   (UNAUDITED)

                                     ASSETS
CURRENT ASSETS:
<S>                                                                           <C>
       Cash & cash equivalents                                                $     11,670
       Accounts receivable (net of allowance for doubtful accounts $15,179)         36,685
       Prepaid expenses                                                              9,180
       Investments in marketable securities                                      1,330,000
                                                                              ------------
              Total current assets                                               1,387,535

PROPERTY AND EQUIPMENT, net                                                        276,708

OTHER ASSETS:
       Deposits                                                                     36,748
       Intangible assets, net                                                        6,447
       Other assets                                                                    883
                                                                              ------------

TOTAL ASSETS                                                                  $  1,708,322
                                                                              ============

                             LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
       Accounts payable & accrued expenses                                    $    587,296
       Factoring payables                                                           20,000
       Payroll and payroll taxes payable                                           176,155
       Payroll taxes assumed in merger                                              96,661
       Current portion of long-term debt                                           136,562
       Loans payable-stockholders                                                   32,300
       Convertible bonds                                                            62,495
       Convertible debentures                                                      100,000
       Convertible notes                                                           500,000
       Deferred revenue                                                             59,600
       Liabilities in process of conversion to stock                               470,629
       Dividend payable                                                              2,813
                                                                              ------------
              Total current liabilities                                          2,244,511

LONG TERM DEBT, net of current portion                                             188,091

CONVERTIBLE DEBENTURES                                                             225,000

SHARES TO BE ISSUED - Series A Redeemable Preferred stock, 2,250,000 shares        360,000

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
       Common stock, .001 par value; authorized shares 200,000,000
       issued and outstanding  shares 71,122,454                                   711,225
       Additional paid in capital                                               23,535,509
       Shares to be issued-Common Stock 1,000,000 shares                           100,000
       Unamortized consulting fees                                                 (66,894)
       Investments held in escrow                                               (1,330,000)
       Accumulated deficit                                                     (24,259,120)
                                                                              ------------
              Total stockholders' deficit                                       (1,309,280)
                                                                              ------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                       1,708,322
                                                                             ============
</TABLE>
   The accompanying notes are an integral part of these financial statements.

                                       4
<PAGE>
<TABLE>
<CAPTION>

                           QUINTEK TECHNOLOGIES, INC.
                            STATEMENTS OF OPERATIONS
          FOR THE THREE MONTH PERIODS ENDED SEPTEMBER 30, 2004 AND 2003
                                   (UNAUDITED)

                                                             2004            2003
                                                        ------------    ------------
<S>                                                     <C>             <C>
Net revenue                                             $    114,266    $    108,177

Cost of revenue                                               84,481          52,910
                                                        ------------    ------------

Gross profit                                                  29,785          55,267

Operating expenses
       Selling, general and administrative                   840,109         165,898
       Stock based compensation                              362,000
                                                        ------------    ------------
Total Operating Expenses                                   1,202,109         165,898
                                                        ------------    ------------
Loss from Operations                                      (1,172,323)       (110,631)

Non-operating income (expense):
       Other income                                            3,325           2,982
       Interest expense                                      (25,443)         (6,060)
                                                        ------------    ------------
Total non-operating income (expense)                         (22,117)         (3,078)

                                                        ------------    ------------
Loss before provision for income taxes                    (1,194,441)       (113,709)

Provision for income taxes                                       800            --

                                                        ------------    ------------
Net loss                                                  (1,195,241)       (113,709)

Dividend requirement for preferred stock                       2,813            --

                                                        ------------    ------------
Net loss applicable to common shareholders              $ (1,198,053)   $   (113,709)
                                                        ============    ============

Basic and diluted weighted average shares outstanding     58,506,835      46,762,008
                                                        ============    ============

Basic and diluted net loss per share                           (0.02)          (0.00)
                                                        ------------    ------------

Basic and diluted net loss per share for dividends
  for preferred stock                                           0.00            0.00
                                                        ------------    ------------

Basic and diluted net loss per share applicable
  to common shareholders                                       (0.02)          (0.00)
                                                        ============    ============
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                       5
<PAGE>

<TABLE>
<CAPTION>
                           QUINTEK TECHNOLOGIES, INC.
                            STATEMENTS OF CASH FLOWS
          FOR THE THREE MONTH PERIODS ENDED SEPTEMBER 30, 2004 AND 2003
                                   (UNAUDITED)
                                                                         2004            2003
                                                                      -----------    -----------
               CASH FLOWS FROM OPERATING ACTIVITIES:
<S>                                                                   <C>            <C>
    Net loss                                                          $(1,198,053)   $  (113,709)
    Adjustments to reconcile net loss to net cash
       provided by (used in) operating activities:
       Depreciation and amortization                                       28,456         11,274
       Stock based compensation                                           362,000           --
       Issuance of stock for consulting services                          170,000           --
       Stock options granted                                                1,500           --
       (Increase) decrease in current assets:
                Accounts receivable                                        (7,949)        67,129
                Inventory                                                    --           (1,384)
                Other assets                                               (8,291)         1,620
                Prepaid expenses                                           (3,916)          --
                Deposits                                                  (28,332)          --
       Increase (decrease) in liabilities:
                Dividend payable                                            2,813
                Accounts payable and accrued expenses                     148,471         43,298
                Payroll and payroll taxes payable                         (10,984)        (7,676)
                Deferred revenue                                          (27,440)          --
                Liabilities in process of conversion to stock                --             --
                                                                      -----------    -----------
    Total adjustments                                                     626,326        114,261
                                                                      -----------    -----------
               Net cash provided (used) in operating activities          (571,727)           552
                                                                      -----------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES
       Purchase of other assets                                              --           (9,092)
                                                                      -----------    -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
       Payments on factoring payables                                     (23,230)      (126,890)
       Proceeds (payment) on loans from stockholders                         --          100,000
       Proceeds( payments) on notes payable,                               (8,973)        18,824
       Proceeds from issuance of debentures                               325,000           --
       Proceeds from issuance of convertible notes                         70,000           --
       Proceeds from issuance of common stock and warrants                205,000           --
                                                                      -----------    -----------
               Net cash provided (used in) by  financing activities       567,797         (8,066)
                                                                      -----------    -----------

NET DECREASE IN CASH & CASH EQUIVALENTS                                    (3,930)       (16,606)

CASH & CASH EQUIVALENTS, BEGINNING BALANCE                                 15,600         21,162
                                                                      -----------    -----------
CASH & CASH EQUIVALENTS, BEGINNING BALANCE                            $    11,670    $     4,556
                                                                      ===========    ===========
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                       6
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)


1.     Description of business

         Quintek  Electronics,  Inc., our predecessor  company,  founded in July
1991, acquired technology, related assets and patent rights to its aperture card
business during 1991 and 1992. On January 14, 1999,  Quintek  Electronics,  Inc.
was acquired in a merger by Pacific  Diagnostics  Technologies,  Inc. as part of
their Chapter 11 Plan of  Reorganization,  and the  surviving  entity's name was
changed to Quintek  Technologies,  Inc.  Since the merger,  Quintek  Electronics
continued  to sell its  aperture  card  products  and all former  operations  of
Pacific Diagnostics Technologies,  Inc. were discontinued. On February 24, 2000,
we  acquired  all  of the  out  standing  shares  of  common  stock  of  Juniper
Acquisition  Corporation.  Upon  effectiveness  of  that  acquisition,   Quintek
Electronics  elected to become the  successor  issuer to Juniper  for  reporting
purposes under the Securities Exchange Act of 1934.

         We have been a  manufacturer  of hardware  and  software  and a service
provider  to the  corporate  and  public  sector  markets  since  1991.  Our new
division,  Quintek Services, Inc. delivers business process outsourcing services
and information  lifecycle management solutions to document intensive industries
such as healthcare and financial  services.  Business process outsourcing is the
delegation,  by the customer,  of the operational  responsibility for a business
process's  execution and  performance  within the  customer's  environment.  The
solutions  and  services we provide  enable  organizations  to secure and manage
their information and document business processes more efficiently.

         Quintek  Services  provides  business process  outsourcing  services to
Fortune  500,  Russell  2000  companies  and public  sector  organizations.  Our
business process  outsourcing  services range from the digitizing,  indexing and
uploading of source  documents  through  simple  customer-specific,  rules-based
decision making.

         We sell  hardware,  software and  services  for  printing  large format
drawings  such as  blueprints  and computer  aided design files  directly to the
microfilm  format of aperture cards. We are the only  manufacturer of a patented
chemical-free desktop microfilm printer for aperture cards.


2.     Basis of Presentation

The accompanying  unaudited financial  statements of Quintek  Technologies,  Inc
(the "Company) have been prepared in accordance  with the rules and  regulations
of the  Securities  and  Exchange  Commission  for the  presentation  of interim
financial  information,  but do not include all the  information  and  footnotes
required by generally  accepted  accounting  principles  for complete  financial

                                       7
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

statements.  In the opinion of management,  the accompanying unaudited financial
statements of the Company  include all  adjustments  (consisting  only of normal
recurring  adjustments)  considered  necessary to present  fairly its  financial
position as of  September  30,  2004,  the results of  operations  for the three
months ended September, 2004 and 2003, and cash flows for the three months ended
September 30, 2004 and 2003.  The  operating  results for the three month period
ended September 30, 2004 are not necessarily  indicative of the results that may
be expected for the year ending June 30, 2005 The audited  financial  statements
for the year  ended  June 30,  2004  were  filed on  October  1,  2004  with the
Securities and Exchange  Commission and is hereby  referenced.  The  information
included in this Form 10-QSB  should be read in  conjunction  with  Management's
Discussion and Analysis and financial  statements and notes thereto  included in
the Company's 2004 Form 10-KSB.


Use of Estimates
The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  the  reported  amounts  of assets  and  liabilities  and  disclosure  of
contingent  assets and  liabilities at the date of the financial  statements and
the  reported  amounts of revenues  and expenses  during the  reporting  period.
Actual results could differ from those estimates.

Research and Development
Research and  development  costs are charged to operations when incurred and are
included in operating  expenses.  The amount charged to operations for the three
months ended September 30, 2004 and 2003 was $15,073 and 12,406, respectively.

Marketable securities

On July 29,  2004,  the Company  entered  into an  Agreement  with  LANGLEY PARK
INVESTMENTS PLC, a London  Investment  Company to issue 14,000,000 shares of the
Company's  common  stock to Langley in return for  1,145,595  shares of Langley.
Fifty percent of Langley shares issued to the Company under this agreement is to
be held in escrow for two years.  The Company has recorded such shares as shares
held in  escrow  amounting  $1,330,000  as  contra  equity  in the  accompanying
financial  statements.  At the end of two  years  if the  market  price  for the
Company's  common  stock is at or greater  than the  Initial  Closing  Price the
escrow agent will  release the full  amount.  In the event that the market price
for the Company's common stock is less than the Initial Closing Price the amount
released will be adjusted.

Langley  attained  listing  with  the  United  Kingdom  Listing  Authority.  The
Company's  shares are to be held by Langley  for a period of at least two years.
Langley shares issued to the Company are to be free trading.

The  Company's  marketable  securities  (Langley's  shares)  are  classified  as
available-for-sale   and,  as  such,  are  carried  at  fair  value.  Securities
classified as available-for-sale  may be sold in response to changes in interest
rates,  liquidity  needs,  and for other purposes.  The investment in marketable
securities  represents less than twenty percent (20%) of the outstanding  common
stock  and  stock  equivalents  of the  investee,  As such,  the  investment  is
accounted for in accordance with the provisions of SFAS No. 115.

Unrealized holding gains and losses for marketable  securities are excluded from
earnings and reported as a separate component of stockholder's equity.  Realized
gains and losses for securities classified as available-for-sale are reported in
earnings  based  upon  the  adjusted  cost of the  specific  security  sold.  On
September 30, 2004, the investments  have been recorded at $1,330,000 based upon
the fair value of the marketable securities.

Marketable  securities  classified  as  available  for  sale  consisted  of  the
following as of September 30, 2004:

                                       8
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                          Market           Accum.         Number of
         Investee Name                Cost at            Value at        Unrealized     Shares Held at
            (Symbol)            September 30, 2004  September 30, 2004  Gain (Loss)  September 30, 2004
---------------------------------------------------------------------------------------------------------
<S>                                     <C>                <C>                   <C>             <C>
 Langley Park Investments, PLC          $ 1,330,000        $ 1,330,000           $ -             572,798

                                -----------------------------------------------------
      Totals                            $ 1,330,000        $ 1,330,000           $ -
                                =====================================================
</TABLE>


Stock based compensation
SFAS No. 123 prescribes  accounting and reporting  standards for all stock-based
compensation plans, including employee stock options, restricted stock, employee
stock  purchase  plans and stock  appreciation  rights.  SFAS No.  123  requires
compensation  expense to be recorded (i) using the new fair value method or (ii)
using the existing  accounting rules  prescribed by Accounting  Principles Board
Opinion No. 25,  "Accounting for stock issued to employees" (APB 25) and related
interpretations  with  proforma  disclosure  of what net income and earnings per
share would have been had the Company  adopted  the new fair value  method.  The
Company  has chosen to account for  stock-based  compensation  using  Accounting
Principles Board Opinion No. 25,  "Accounting for Stock Issued to Employees" and
has  adopted  the  disclosure   only   provisions  of  SFAS  123.   Accordingly,
compensation  cost for stock  options is measured as the excess,  if any, of the
quoted  market  price of the  Company's  stock at the date of the grant over the
amount an employee is required to pay for the stock.

The  Company's  board  of  directors  authorized  a stock  award  and  long-term
incentive  plan which  includes  stock  appreciation  rights and  certain  stock
incentive awards. The plan was approved by the shareholders as of June 30, 2004.

Basic and diluted net loss per share

Net loss per share is calculated  in accordance  with the Statement of financial
accounting  standards No. 128 (SFAS No. 128), "Earnings per share". SFAS No. 128
superseded  Accounting  Principles  Board  Opinion  No.15 (APB 15). Net loss per
share for all periods  presented  has been  restated to reflect the  adoption of
SFAS No. 128. Basic net loss per share is based upon the weighted average number
of  common  shares  outstanding.  Diluted  net  loss  per  share is based on the
assumption that all dilutive convertible shares and stock options were converted
or exercised.  Dilution is computed by applying the treasury stock method. Under
this method,  options and warrants are assumed to be exercised at the  beginning
of the period (or at the time of issuance,  if later),  and as if funds obtained
thereby were used to purchase  common  stock at the average  market price during
the period. Issuance of shares for service

                                       9
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

The Company accounts for the issuance of equity instruments to acquire goods and
services  based on the fair value of the goods and services or the fair value of
the  equity  instrument  at the time of  issuance,  whichever  is more  reliably
measurable.

Reporting segments

Statement of financial  accounting standards No. 131, Disclosures about segments
of an  enterprise  and related  information  (SFAS No.  131),  which  superseded
statement of financial  accounting  standards  No. 14,  Financial  reporting for
segments of a business enterprise, establishes standards for the way that public
enterprises  report  information  about operating  segments in annual  financial
statements  and  requires  reporting  of selected  information  about  operating
segments  in interim  financial  statements  regarding  products  and  services,
geographic areas and major customers. SFAS No. 131 defines operating segments as
components  of an  enterprise  about which  separate  financial  information  is
available that is evaluated  regularly by the chief operating  decision maker in
deciding how to allocate  resources  and in assessing  performances.  Currently,
SFAS 131 has no effect on the Company's  financial  statements as  substantially
all of the Company's operations are conducted in one industry segment.

Reclassifications

Certain  comparative  amounts have been reclassified to conform with the current
period presentation.

Recent Pronouncements

In  December  2002,  the FASB issued  SFAS No. 148  "Accounting  for Stock Based
Compensation-Transition  and  Disclosure".  SFAS No.  148 amends  SFAS No.  123,
"Accounting for Stock Based  Compensation",  to provide  alternative  methods of
transition  for a voluntary  change to the fair value based method of accounting
for stock-based employee  compensation.  In addition,  this Statement amends the
disclosure  requirements  of Statement 123 to require  prominent  disclosures in
both annual and interim financial  statements about the method of accounting for
stock-based employee compensation and the effect of the method used, on reported
results.  The Statement is effective for the Companies' interim reporting period
ending January 31, 2003.

In  compliance  with FAS No. 148,  the Company has elected to continue to follow
the  intrinsic  value  method  in  accounting  for  its   stock-based   employee
compensation  plan  as  defined  by APB  No.  25 and  has  made  the  applicable
disclosures below.

Had the Company  determined  employee stock based  compensation  cost based on a
fair value  model at the grant date for its stock  options  under SFAS 123,  the
Company's  net  earnings  per share  would have been  adjusted  to the pro forma
amounts  for the period  ended  September  30,  2004 and 2003,  as follows ($ in
thousands, except per share amounts):

                                       10
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)


                                                 Period ended September 30,
                                                    2004           2003
                                               -------------     -----------

     Net loss - as reported                    $  (1,194$             (114)
     Stock-Based employee compensation
       expense included in reported net
       income, net of tax                           --                --

     Total stock-based employee
       compensation expense determined
       under fair-value-based method for all
       rewards, net of tax                          (362)             --
                                               -------------     -----------
     Pro forma net loss                        $  (1,556)        $    (114)
                                               =============     ===========
E    arnings (loss) per share:

     Basic, as reported                        $      (0.02)     $    (0.00)
     Diluted, as reported                      $      (0.02)     $    (0.00)
     Basic, pro forma                          $      (0.02)     $    (0.00)
     Diluted, pro forma                        $      (0.02)     $    (0.00)

On May 15 2003, the FASB issued FASB Statement No. 150 ("SFAS 150"),  Accounting
for Certain Financial  Instruments with  Characteristics of both Liabilities and
Equity. SFAS 150 changes the accounting for certain financial  instruments that,
under previous guidance, could be classified as equity or "mezzanine" equity, by
now requiring  those  instruments to be classified as liabilities  (or assets in
some  circumstances) in the statement of financial position.  Further,  SFAS 150
requires  disclosure  regarding the terms of those  instruments  and  settlement
alternatives.  SFAS 150  affects an  entity's  classification  of the  following
freestanding  instruments:  a) Mandatorily  redeemable  instruments b) Financial
instruments  to  repurchase  an entity's  own equity  instruments  c)  Financial
instruments embodying obligations that the issuer must or could choose to settle
by issuing a variable  number of its shares or other  equity  instruments  based
solely on (i) a fixed monetary amount known at inception or (ii) something other
than  changes  in its own  equity  instruments  d) SFAS 150  does  not  apply to
features  embedded in a financial  instrument  that is not a  derivative  in its
entirety.  The guidance in SFAS 150 is  generally  effective  for all  financial
instruments  entered  into or  modified  after May 31,  2003,  and is  otherwise
effective at the beginning of the first interim period  beginning after June 15,
2003. For private companies,  mandatorily  redeemable financial  instruments are
subject to the  provisions  of SFAS 150 for the fiscal  period  beginning  after
December 15, 2003. The adoption of SFAS No. 150 does not have a material  impact
on the Company's financial position or results of operations or cash flows.

In December  2003,  the  Financial  Accounting  Standards  Board (FASB) issued a
revised  Interpretation  No. 46,  "Consolidation of Variable Interest  Entities"
(FIN 46R). FIN 46R addresses  consolidation by business  enterprises of variable
interest  entities and significantly  changes the  consolidation  application of
consolidation   policies  to  variable  interest  entities  and,  thus  improves
comparability  between  enterprises  engaged  in similar  activities  when those
activities are conducted  through variable interest  entities.  The Company does
not hold any variable interest entities.

                                       11
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

In March 2004, the Emerging  Issues Task Force  ("EITF")  reached a consensus on
Issue  No.  03-1,  "The  Meaning  of  Other-Than-Temporary  Impairment  and  its
Application  to Certain  Investments."  The EITF  reached a consensus  about the
criteria  that should be used to  determine  when an  investment  is  considered
impaired,  whether that impairment is other-than-temporary,  and the measurement
of an  impairment  loss and how that criteria  should be applied to  investments
accounted for under SFAS No. 115, "ACCOUNTING IN CERTAIN INVESTMENTS IN DEBT AND
EQUITY   SECURITIES."  EITF  03-01  also  included   accounting   considerations
subsequent to the recognition of an other-than-temporary impairment and requires
certain  disclosures  about  unrealized  losses that have not been recognized as
other-than-temporary   impairments.   Additionally,   EITF  03-01  includes  new
disclosure  requirements  for  investments  that are  deemed  to be  temporarily
impaired.  In September  2004, the Financial  Accounting  Standards Board (FASB)
delayed  the  accounting  provisions  of  EITF  03-01;  however  the  disclosure
requirements remain effective for annual reports ending after June 15, 2004. The
Company will evaluate the impact of EITF 03-01 once final guidance is issued.


In April of 2004,  the EITF reached  consensus on the guidance  provided in EITF
Issue No. 03-6,  "Participating  Securities and the Two-Class  Method under SFAS
No. 128  Earnings  Per  Share"  ("EITF  03-6").  EITF 03-6  clarifies  whether a
security  should be  considered  a  "participating  security"  for  purposes  of
computing  earnings per share ("EPS") and how earnings  should be allocated to a
"participating  security"  when using the two-class  method for computing  basic
EPS.  The  adoption  of EITF  03-6  does not have a  significant  impact  on the
Company's financial position or results of operations.


In May of 2004,  the  FASB  revised  FASB  Staff  Position  ("FSP")  No.  106-1,
"Accounting  and Disclosure  Requirements  Related to the Medicare  Prescription
Drug,  Improvement  and  Modernization  Act of 2003" and issued  FSP No.  106-2,
"Accounting  and Disclosure  Requirements  Related to the Medicare  Prescription
Drug,  Improvement and Modernization  Act of 2003" ("FSP No. 106-2").  FSP 106-2
provides accounting guidance to the employers who sponsor post retirement health
care plans that provide  prescription  drug benefits;  and the prescription drug
benefit provided by the employer is "actuarially  equivalent" to Medicare Part D
and hence  qualifies  for the subsidy  under the  Medicare  amendment  act.  The
adoption  of FSP  106-2  does not have a  significant  impact  on the  Company's
financial position or results of operations.

SEC  Staff  Accounting  Bulletin  (SAB)  No.  105,  "APPLICATION  OF  ACCOUNTING
PRINCIPLES TO LOAN  COMMITMENTS,"  summarizes  the views of the staff of the SEC
regarding the application of generally  accepted  accounting  principles to loan
commitments  accounted for as derivative  instruments.  SAB No.105 provides that
the  fair  value  of  recorded  loan  commitments  that  are  accounted  for  as
derivatives  under SFAS No. 133,  "ACCOUNTING  FOR  DERIVATIVE  INSTRUMENTS  AND
HEDGING  ACTIVITIES,"  should not  incorporate  the  expected  future cash flows
related to the associated servicing of the future loan. In addition, SAB No. 105
requires  registrants to disclose their accounting  policy for loan commitments.
The provisions of SAB No. 105 must be applied to loan commitments  accounted for
as derivatives  that are entered into after March 31, 2004. The adoption of this
accounting  standard does not have a material impact on the Company's  financial
statements.


                                       12

<PAGE>
                            QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)


3.      PROPERTY AND EQUIPMENT

Property and equipment at September 30, 2004, consists of the following:

              Scanning Equipment              $ 193,677
              Computer and office equipment     111,752
                Other depreciable assets        102,880
               Software                          76,164
              Furniture and fixture              35,589
                                              ---------
                                                520,062
              Accumulated depreciation         (243,354)
                                              ---------
                                              $ 276,708
                                              =========

4.       INTANGIBLE ASSETS
The  Company  evaluates  intangible  assets  and  other  long-lived  assets  for
impairment,  at least on an annual  basis and  whenever  events  or  changes  in
circumstances  indicate that the carrying value may not be recoverable  from its
estimated  future  cash  flows.   Recoverability  of  intangible  assets,  other
long-lived assets and, goodwill is measured by comparing their net book value to
the related projected  undiscounted cash flows from these assets,  considering a
number  of  factors  including  past  operating   results,   budgets,   economic
projections, market trends and product development cycles. If the net book value
of the  asset  exceeds  the  related  undiscounted  cash  flows,  the  asset  is
considered  impaired,  and a second test is  performed  to measure the amount of
impairment  loss.  Potential  impairment of goodwill after July 1, 2002 has been
evaluated in accordance with SFAS No. 142. The SFAS No. 142 is applicable to the
financial  statements  of the Company  beginning  July 1, 2002.  Net  intangible
assets at September 30, 2004 were as follows:

                Patents and proprietary processes    $   136,067
                Accumulated amortization                 129,620
                                                     -----------
                                                     $     6,447
                                                     ===========

Amortization  expenses  for the  Company's  intangible  assets  over the  future
periods  are  estimated  to  be:  Twelve  months  period  ended   September  30,
2005-$6,447.

5.       EMPLOYEE RECEIVABLES

                 Notes receivable from employees, unsecured,
                    due on June 30, 2019, interest at 4%         $ 377,649

                 Interest receivable in connection with
                    above notes receivable                          18,385
                                                                 ---------
                                                                   396,034
                 Valuation allowance                              (393,208)
                                                                 ---------
                                                                 $   2,826
                                                                 =========


                                       13
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

 6.      FACTORING PAYABLE

The  Company has  entered  into an  agreement  with a  factoring  company  ("the
Factor") to factor  purchase  orders with recourse.  The Factor funds 97% or 90%
based upon the status of the purchase  order.  The Factor has agreed to purchase
up to $4,800,000 of qualified  purchase  orders over the term of the  agreement;
however,  the Factor does not have to purchase  more than  $200,000 in any given
month. The agreement term is from June 2, 2003 to June 2, 2005. The Company will
pay a late fee of 3% for  payments  not made within 30 days and 5% for those not
made in 60 days.  At the  option of the  Factor,  the late fees may be paid with
Company stock. If paid by Company stock,  the stock bid price will be discounted
50% in computing the shares to be issued in payment of the late fee.

The Company has agreed to issue the Factor  1,500,000  warrants  purchasing  the
Company's stock as a fee for the factoring agreement. The stock issued under the
warrants can be purchased at the average  closing price of the  Company's  stock
for the 90 days prior to the factoring agreement.

The Company has also issued the Factor bonus  warrants.  The Factor will receive
two (2) bonus warrants for each dollar of purchase orders  purchased.  The bonus
warrants  will be  exercisable  at the average  closing  price of the  Company's
common  stock for the 90 days  prior to the  purchase  order  transactions  they
represent or a 50% discount to the closing price of the  Company's  stock at the
time  exercised at the option of the Factor.  Both  warrants are for a five year
period.

At September 30, 2004, the Company had a factoring payable balance of $20,000.

7.       PAYROLL TAXES-ASSUMED IN MERGER

The  Company  assumed  $205,618 of payroll  tax  liabilities  in the merger with
Pacific Diagnostic  Technologies,  Inc. The balance was $96,661 at September 30,
2004. The Company is delinquent on payments of these payroll tax liabilities.

8.     LONG TERM PAYABLES
<TABLE>
<CAPTION>

<S>                                                                          <C>
            Leases payable, interest at 7.9% to 20%, due various dates       $ 273,680
             in 2005 to 2008
            Note payable, DFS, interest at 15.99%, due Jun & Jul 2006            2,720
            Notes payable, AP conversion, interest at 8%, due 2006              44,208
            Note payable - Vendor, monthly installments $404, July 2005          4,045

                                                                               324,653
            Current portion                                                    136,562
                                                                             $ 188,091

            The future maturity of the long term payables is as follows:

                                                     2005                    $ 136,562
                                                     2006                      110,699
                                                     2007                       77,392
                                                     Total                   $ 324,653
                                                                             =========
</TABLE>


                                       14
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)


9.          CONVERTIBLE BONDS
<TABLE>
<CAPTION>
<S>                                                                           <C>
         Bonds payable with interest at 9%, due on various
         dates in 2001 and 2002, convertible to shares of
         Common stock in increments of $1,000 or more.                        $ 21,354

         Bonds  payable  with  interest at 12%,  due July 2002,
         convertible to shares of common stock in increments
         of $500 or more.                                                       41,141
                                                                              --------
                                                                             $  62,495
                                                                             =========
</TABLE>

Certain of the  outstanding  convertible  bonds have  matured as of December 31,
2002.  The holders of the matured  bonds do not wish to renew the bonds and have
asked for  payment;  however,  the Company does not have the cash to repay these
bonds.

Bondholders  have been asked to  exchange  their  bonds for  Series B  preferred
stock.  As of  September  30, 2004,  holders of $198,000 of the bonds  including
accrued  interest had acted on this.  The $198,000 is included in the  liability
section of the financials under "Liabilities in Process of Conversion to Stock,"
since the preferred stock has not been issued.

10.        CONVERTIBLE DEBENTURES

During the period ended  September 30, 2004, the Company raised capital  through
the issuance of convertible debentures in the amount of $325,000.

One debenture in the amount of $300,000  pays  interest at 5 3/4%  interests and
includes 3,000,000 warrants to purchase common stock for a period of three years
at $1.00.  The "Conversion  Price" shall be equal to the lesser of (i) $0.50, or
(ii) 80% of the average of the 5 lowest Volume  Weighted  Average  Prices during
the 20 Trading Days prior to Holder's  election to convert,  or (iii) 80% of the
Volume Weighted  Average Price on the Trading Day prior to Holder's  election to
convert  market price of the Company's  common stock prior to  conversion.  Upon
conversion of the debenture,  the fund is obligated to  simultaneously  exercise
the $1.00 warrants  providing added funding to the company.  The Warrant must be
exercised  concurrently with the conversion of this Debenture in an amount equal
to ten times the dollar amount of the Debenture  conversion.  Upon  execution of
the securities  purchase  agreement,  $225,000 of the purchase price was due and
paid to the Company.  The remaining  $75,000 is due the Company upon declaration
from the Securities and Exchange Commission that the Registration  Statement for
the conversion shares and warrants is effective.

A second agreement consists of 2 convertible  debentures each for $100,000 which
bears simple  interest at 10%. The initial  Debenture for $100,000 was purchased
during August 2004. The second  Debenture for $100,000 will be purchased  within
five days of a  registration  statement  being declared  effective  covering the
Conversion Shares and Warrant Shares. Debentures are convertible into the Common
stock of the Company. Conversion Price per share shall be the lower of (i) $0.10
("Maximum  Base  Price");  or (ii) in the  event  the  Borrower  enters  into an
agreement  subsequent to execution of the Securities  Purchase Agreement to sell
Common Stock or a convertible  instrument  that converts into Common Stock prior
to conversion  of this  Debenture at a price less than the  Conversion  Price of
this Debenture, then the Conversion Price of this Debenture shall be immediately
reset to a lower  Conversion  Price equal to that  described  in the  subsequent
agreement.  Warrants are exercisable at $0.12 per share into the Common Stock of
the Company and expire on August 17, 2007.

                                       15
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

The  conversion  right of the  debenture  holder with respect to the  individual
debentures   shall  only  exist  upon  the  Company's   registration   statement
registering  the Shares  underlying the debentures  and other  Securities  being
declared  effective by the Securities and Exchange  Commission.  As of September
30, 2004, the criteria to convert the debentures to common stock were not met.

The  total  interest  on  these  convertible  debentures  for the  period  ended
September 30, 2004 amounted to $3,326.

11.         CONVERTIBLE NOTES

During the year ended June 30,  2004,  the Company  raised  capital  through the
issuance of  convertible  promissory  notes in the amount of  $500,000.  All the
notes are for a one year period and bear simple interest at the rate of 10%. The
due dates of these notes are from November 26, 2004 through June 4, 2005.

The  notes  plus  any  accrued  interest  through  the  date of  conversion  are
convertible to the common stock of the Company at $.06. Additionally, the holder
will receive one bonus  warrant for each  conversion  share.  Each bonus warrant
will be  exercisable  for a period of 5 years from the date of issuance into one
share of common stock at a price of $.10.

 The conversion  right of the note holder with respect to the  individual  notes
shall only exist upon:  (i) the  approval of a proxy  statement to be filed with
the  Securities  and  Exchange  Commission  and  approval of an amendment by the
Company's  shareholders  to  authorize  to  200,000,000  the number of shares of
common  stock and (ii) the  Company's  registration  statement  registering  the
Shares underlying the notes and other Securities has been declared  effective by
the Securities and Exchange  Commission.  As of September 30, 2004, the criteria
to convert the notes to common stock were not met.

The total interest on these  convertible notes for the period September 30, 2004
amounted to $12,500.

12.        LIABILITIES IN PROCESS OF CONVERSION TO STOCK

The Company  has a total of $470,629  liabilities  in process of  conversion  to
stock as of September 30, 2004. This amount consists of the following:

                  Bond payable                              $ 198,268
                  Accounts payable                             20,147
                  Payrolls payable                            252,214
                                                            ---------
                                                            $ 470,629
                                                            =========

Bonds for $188,268 are  convertible to one share of Series A Preferred stock for
each $.05 of debt owed by the Company.  Remaining $10,000 bond is convertible to
one share of Series B Preferred stock for each $.25 of debt owed by the Company.

Accounts  payable are  convertible to one share of Series C Preferred  stock for
each $1.00 of payable owed by the Company.

Payrolls  payable are  convertible to one share of Series A Preferred  stock for
each $.25 of debt owed by the Company.


                                       16
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

14.       LOANS PAYABLE - STOCKHOLDERS

The  Company  has a loan  payable  balance  of $32,300  to the  stockholders  at
September 30, 2004. These loans are interest free, unsecured and due on demand.

15.      STOCKHOLDERS' EQUITY

a.       Common Stock and Warrants

The Company has authorized 50 million shares of common stock with a par value of
$0.001  per  share.  Each share  entitles  the holder to one vote.  There are no
dividend or liquidation preferences, participation rights, call prices or rates,
sinking  fund  requirements,  or unusual  voting  rights  associated  with these
shares. During the year ended June 30, 2003, the Company established the Class L
warrants and initiated the process of  establishing  the Class A Preferred stock
which underlies these warrants.

During the period ended  September 30, 2004,  2,043,888,  shares of common stock
were issued for services valued at $170,000.

During the period ended  September  30, 2004,  4,682,572  shares of common stock
were issued for conversion of loans from shareholders bond amounting $211,756.

During the period ended  September 30, 2004,  $70,000 of outstanding  notes were
converted  to  700,000  shares  of  common  stock.   In  connection   with  this
transaction, $28,297 of beneficial conversion feature expense was recorded.

On  September  15,  2004,  the  Company  agreed to issue and sell to an Investor
1,000,000  shares of the  Company's  Common  Stock and  warrants  purchase up to
1,000,000  shares of Common  Stock.  The  investor  purchased  from the  Company
1,000,000  shares of Common  Stock of the  Company  for $.10 per  share,  for an
aggregate  of  $100,000,  and also  received  from the Company  (a)  warrants to
purchase up to 1,000,000 shares of Common Stock of the Company at $.13 per share
at any time through September 15, 2007.

The Company  agreed to provide  with  respect to the Common Stock as well as the
Common Stock issuable upon exercise of the Warrants certain  registration rights
under the Securities Act;


Upon  surrender  of either a Class J or L  warrant,  the holder is  entitled  to
purchase one share of the Company's stock at the designated  exercise price. For
each warrant class, the number of warrants outstanding,  the exercise price, the
type of underlying stock, and the expiration dates are defined as follows:

Class L - warrants were  established  in March 2003,  with an exercise  price of
$.25 per share, an expiration date of January 14, 2005 and Series A Preferred as
underlying  stock.  As of June 30,  2004,  holders  of Class J  exchanged  their
warrants for 3,063,432 Class L Warrants.


                                       17
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)


During the year ended June 30, 2004,  200,000 shares of warrants were issued for
consulting  services for three years beginning February 2004, valued at $41,572.
$3,464 was amortized  during the period ended September 30, 2004. The fair value
of the warrants is estimated  on the grant date using the  Black-Scholes  Model.
The following assumptions were made in estimating fair value.

Annual rate of quarterly dividends                            0.00%
Discount rate - Bond Equivalent Yield                         3.50%
Expected life                                               3 years
Expected volatility                                            100%

       b.    Common Stock Reserved

At September 30, 2004, common stock was reserved for the following reasons:

        Outstanding convertible bond                     151,919 shares
        Exercise of Class L warrants                   3,063,432 shares


             Warrants
                                                        Number
                                                          of
                                                        Warrants
                                                        --------


         Outstanding June 30, 2004                     3,263,432
         Issued during the period                      1,000,000
         Exercised                                             0
                                                       ---------
         Outstanding September 30, 2004                4,263,432
                                                       =========

       c.    Stock Option Agreements

The Company granted 50,000 stock options to one employee during the period ended
September 30, 2004.

The  Company  recorded $ 1,500 as  compensation  expense  due to issuance of the
options, during the period ended September 30, 2004.

The number  and  weighted  average  exercise  prices of  options  granted by the
Company are as follows:

              Options

                                                       Number
                                                         of
                                                       Options
                                                       --------
         Outstanding June 30, 2004                     2,215,000
         Granted during the period                        50,000
         Exercised                                             0
         Expired/forfeited                                     0
                                                       ---------
         Outstanding September 30, 2004                2,265,000


                                       18
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

In  December  2002,  the FASB issued  SFAS No. 148  "Accounting  for Stock Based
Compensation-Transition  and  Disclosure".  SFAS No.  148 amends  SFAS No.  123,
"Accounting for Stock Based  Compensation",  to provide  alternative  methods of
transition  for a voluntary  change to the fair value based method of accounting
for stock-based employee  compensation.  In addition,  this Statement amends the
disclosure  requirements  of Statement 123 to require  prominent  disclosures in
both annual and interim financial  statements about the method of accounting for
stock-based employee compensation and the effect of the method used, on reported
results.  The Statement is effective for the Companies' interim reporting period
ending January 31, 2003.

In  compliance  with FAS No. 148,  the Company has elected to continue to follow
the  intrinsic  value  method  in  accounting  for  its   stock-based   employee
compensation  plan  as  defined  by APB  No.  25 and  has  made  the  applicable
disclosures below.

Had the Company  determined  employee stock based  compensation  cost based on a
fair value  model at the grant date for its stock  options  under SFAS 123,  the
Company's  net  earnings  per share  would have been  adjusted  to the pro forma
amounts for the six month ended June 30, 2004 as follows ($ in thousands, except
per share amounts). :


            Net loss - as reported                    $      (1198)
            Stock-Based employee compensation
              expense included in reported net
              income, net of tax
                                                                -
            Total stock-based employee
              compensation expense determined
              under fair-value-based method for all
              rewards, net of tax                               (1)
                                                        -------------
            Pro forma net loss                        $     (1,199)
                                                        =============
            Earnings per share:
            Basic, as reported                        $       0.02
            Diluted, as reported                      $       0.02
            Basic, pro forma                          $       0.02
            Diluted, pro forma                        $       0.02

The assumptions  used in calculating the fair value of options granted using the
Black-Scholes option- pricing model are as follows:

                  Expected life (years)                       1  year
                  Risk-free interest rate             1.40% and 3.40%
                  Dividend yield                             0% and 0%
                  Volatility                             45% and 100%

      d. Stock transactions approved by the shareholder's

At the annual meeting of the  shareholders  held June 30, 2004, the shareholders
approved  by a majority  vote to increase to  200,000,000  shares,  no par value
common stock,  and  50,000,000  shares no par value,  preferred  stock which the
corporation  shall have authority to issue. The board of directors is authorized
to divide the  preferred  stock  into any  number of classes or series,  fix the
designation  and  number of  shares  of each  such  series or class and alter or
determine the rights, preferences, privileges and restrictions of each or series
of preferred stock Series A Preferred Stock

                                       19
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

The  general  terms of the Series A Preferred  Stock is as follows:  Par value -
$0.00;  Liquidation  Preference  - $0.25 per share plus any  unpaid  accumulated
dividends;  Dividends -  cumulative  annual rate of $0.005 per share when and as
declared by the Board of Directors;  Conversion  Rights - convertible  to common
stock at a 1:1 ratio ;  Redemption  Rights - the Company has the right to redeem
part or all of the  stock  upon 30 days  written  notice  at a rate of $0.25 per
share plus all accumulated and unpaid dividends  thereon at the dividend rate of
$0.005  annually  per share;  Voting  Rights - one vote per share on all matters
requiring  shareholder  vote. At September  30, 2004,  the Company had 2,250,000
shares of Series A Preferred Stock to be issued valued at $360,000.  The Company
has recorded a cumulative dividend of $2,813 for the preferred  stockholders for
the three month period ended September 30, 2004, in the  accompanying  financial
statements.

Series B Preferred Stock

The  general  terms of the Series B Preferred  Stock is as follows:  Par Value -
$0.00;  Liquidation  Preference  - $0.25 per share plus any  unpaid  accumulated
dividends;  Dividends - cumulative  annual rate of $0.0005 per share when and as
declared by the Board of Directors;  Conversion  Rights - convertible  to common
stock at a 1:5 ratio (i.e.  1 share of Series B Preferred  stock is  convertible
into 5 shares of common stock) ;  Redemption  Rights - the Company has the right
to redeem  part or all of the  stock  upon 30 days  written  notice at a rate of
$0.25 per  share  plus all  accumulated  and  unpaid  dividends  thereon  at the
dividend rate of $0.0005 annually per share;  Voting Rights - one vote per share
on all matters requiring shareholder vote.

Series C Preferred Stock

The  general  terms of the Series C Preferred  Stock is as follows:  Par value -
$0.00;  Liquidation  Preference  - $1.00 per share plus any  unpaid  accumulated
dividends;  Dividends  -  cumulative  annual  rate of $.0005  per share  when as
declared by the Board of Directors; Conversion Rights - 1:20 ratio (i.e. 1 share
of  Preferred  Series C stock is  convertible  into 20 shares of common  stock);
Redemption Rights - the Company has the right to redeem part or all of the stock
upon 30 days written notice at the rate of $1.00 per share plus all  accumulated
and unpaid dividends thereon at the dividend rate of $.0005 annually per share.;
Voting Rights - one vote per share on all matters requiring shareholder vote.

Liabilities in process of conversion to stock:

The Company has entered into  agreements  with various  vendors and employees to
convert  their  liabilities  into the  above,  three  preferred  series of stock
pending approval of same. The conversion rate varies. (note 12)

17.   SUPPLEMENTAL DISCLOSURE OF CASH FLOWS

The Company  prepares its statements of cash flows using the indirect  method as
defined under the Financial Accounting Standard No. 95.

The Company paid $-0- for income tax during the period ended September 30, 2004.
The Company paid $9,754 interest during the period ended June 30, 2004.

                                       20
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

The cash flow  statement for the period ended ended  September 30, 2004 does not
include the following non-cash investing and financing transactions;

         o    4,682,572  shares of common  stock were issued for  conversion  of
              loans from stockholders amounting to $211,756.
         o    Machinery and equipment was acquired through financing  agreements
              in the amount of $223,242.
         o    1,145,595  of shares of a publicly  held entity were  purchased in
              exchange for 14,000,000  shares of the Company's common stock. The
              shares received were valued at $2,660,000.  Of this amount 572,798
              are trading shares, the remaining 572,797 shares are being held in
              escrow.

18.    COMMITMENTS AND CONTINGENCIES

a)    Operating Leases
Effective July 1, 2004 the Company relocated its executive offices to Huntington
Beach,  California and entered into a four year lease  agreement.  The agreement
contains a base rent  escalation  clause.  The Company  leases its Idaho  office
facility under a  month-to-month  rental  agreement at $1,384 per month. For the
period  ended June 30, 2004 rent  expense  for these  operating  leases  totaled
$29,711.


The future minimum lease payments under non-cancelable leases are as follows:

                       2005                  $  79,000
                       2006                     81,000
                       2007                     83,000
                       2008                     64,000
                                             ---------
                                             $ 307,000
                                             =========

The Company has not filed income tax returns for several years. Due to operating
losses,  income tax liability and penalties would not be  substantial.  However,
the State of California could  potentially  revoke the Company's  charter if the
Company does not become current on its income tax return filings.

d)    Securities and Exchange Commission Inquiry

On  September  17,  2002,  the  Company  was  advised  by the  staff of the U.S.
Securities and Exchange  Commission that they will recommend that the Commission
file civil injunctive

Lawsuits against the Company and its president,  Thomas W. Sims. The suits would
allege that the Company violated Section 17(a) of the Securities Act of 1933 and
Sections 10(b) and 13(a) of the Securities Exchange Act of 1934 and Rules 10b-5,
13a-1,  and 13a-13,  based on false and misleading  statements in press releases
disseminated by the Company on October 22, 2001 and October 25, 2001,  regarding
the Company's investment in PanaMed Corp. and the press releases disseminated on
January  8, 2002 and March 20,  2002,  and  failure  to timely  file  annual and
quarterly  reports with the  Commission.  On March 25, 2003, the Company signed,
without admitting or denying the allegations,  a proposed  settlement  agreement
with the U.S. Securities and Exchange  Commission,  which permanently  restrains


                                       21
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

and enjoins the Company from engaging in acts which would constitute  violations
of these  regulations  in the future.  On August 6, 2003,  a final  judgment was
entered by the U.S. District Court, Central District of California,  against the
Company which  permanently  enjoined the Company from violating Section 10(b) of
the Exchange  Act and Rule 10b-5  promulgated  thereunder  by using any means or
instrumentality  of  interstate  commerce,  or of the mails,  or of any national
securities  exchange:  (A) to employ any device,  scheme or artifice to defraud;
(B) to make any untrue  statement  of a  material  fact or  omitting  to state a
material fact  necessary in order to make the  statements  made, in the light of
the circumstances  under which they were made, not misleading;  or (C) to engage
in any act, practice, or course of business which operates or would operate as a
fraud or deceit upon any person,  in connection with the purchase or sale of any
security.  Further,  the final  judgment  permanently  enjoined the Company from
violating  Section  13(a)  of the  Exchange  Act  and  Rules  13a-1  and  13a-13
promulgated  thereunder,  by failing to file with the  Commission  in accordance
with Commission rules and regulations, information and documents required by the
Commission  to keep current  information  and  documents  required in or with an
application  or  registration  statement  filed  pursuant  to  Section 12 of the
Exchange Act or annual or quarterly reports as the Commission has prescribed.

d)   Litigation

During the year ended  June 30,  2004,  a  creditor  of the  Company  filed suit
against  the  Company  for  $22,662  for goods  provided.  The  Company  filed a
counterclaim in August 2004.

The  $22,662 is  included  in  accounts  payable  and  accrued  expenses  in the
accompanying financial statements.

19.   BASIC AND DILUTED NET LOSS PER SHARE

Net loss per share is calculated  in accordance  with the Statement of financial
accounting  standards  No. 128 (SFAS No. 128),  "Earnings  per share." Basic net
loss per share is based  upon the  weighted  average  number  of  common  shares
outstanding.  Diluted  net loss per  share is based on the  assumption  that all
dilutive  convertible  shares and stock  options were  converted  or  exercised.
Dilution is computed by applying the treasury  stock method.  Under this method,
options and warrants are assumed to be exercised at the  beginning of the period
(or at the time of issuance,  if later),  and as if funds obtained  thereby were
used to purchase common stock at the average market price during the period.

Weighted  average  number of shares used to compute  basic and diluted  loss per
share for the years  ended June 30,  2004 and 2003 are the same since the effect
of dilutive securities is anti-dilutive.

20.    GOING CONCERN

The  accompanying  financial  statements  have been prepared in conformity  with
generally accepted accounting principles,  which contemplate continuation of the
Company as a going concern.  This basis of accounting  contemplates the recovery
of the Company's  assets and the  satisfaction  of its liabilities in the normal
course of  business.  Through  September  30,  2004,  the Company  had  incurred
cumulative losses of $24,256,306 including net losses of $1,198,053 and $113,709
for the periods ended September 30, 2004 and 2003  respectively.  In view of the
matters described in the preceding paragraph,  recoverability of a major portion
of the  recorded  asset  amounts  shown  in the  accompanying  balance  sheet is
dependent upon continued  operations of the Company,  which in turn is dependent


                                       22
<PAGE>

                              QUINTEK TECHNOLOGIES,
                        NOTES TO THE FINANCIAL STATEMENTS
                                   (Unaudited)

upon the Company's ability to raise additional capital,  obtain financing and to
succeed in its future  operations.  The financial  statements do not include any
adjustments  relating to the recoverability and classification of recorded asset
amounts or amounts and  classification  of  liabilities  that might be necessary
should the Company be unable to continue as a going concern.

Management  has taken the following  steps to revise its operating and financial
requirements,  which it believes are  sufficient to provide the Company with the
ability to continue as a going concern.  Management devoted  considerable effort
during the period ended  September 30, 2004,  towards (i)  obtaining  additional
equity  financing (ii)  controlling  of salaries and general and  administrative
expenses  (iii)  management  of  accounts  payable  and (iv)  evaluation  of its
distribution and marketing methods.

21.  SUBSEQUENT EVENTS

During October 2004, the Company converted  various  liabilities and stock based
compensation to shares of stock as follows:


400,000 shares of common stock were issued as repayment of $32,300 in loans from
a stockholder.  As part of the agreement, the Company forgave $6,000 owed to the
Company by the stockholder.

1,008,054  shares of Series A preferred stock were issued as conversion of $252,
213 in back payroll. The Series A preferred stock is convertible to common stock
on a 1:1 basis.

2,250,000  shares of Series A preferred  stock were issued as  compensation  for
services  in the amount of  $340,000.  250,000  shares  valued at  $40,000  were
recorded as shares to be issued during the year ended June 30, 2004.  The series
A preferred stock is convertible to common stock on a 1:1 basis.

724,077 shares of Series A preferred stock were issued for a $36,204 convertible
bond.  The series A  preferred  stock is  convertible  to common  stock on a 1:1
basis.

648,255  shares  of  Series B  preferred  stock  were  issued  for  $162,064  in
convertible bonds. The Series B preferred stock is convertible into common stock
on a 1:5 basis.  One share of Series B  preferred  stock is  convertible  into 5
shares of common stock.

32,000  shares of Series B  preferred  stock and  175,000  of common  stock were
issued  to  satisfy  a past  due  agreement.  The  Series B  preferred  stock is
convertible  into common  stock on a 1:5 basis.  One share of Series B preferred
stock is convertible into 5 shares of common stock.

20,148  shares of Series C preferred  stock were issued in conversion of $20,148
in accounts  payable.  The Series C preferred  stock is convertible  into common
stock on a 1:20 basis. One share of Series C preferred stock is convertible into
20 shares of common stock.

                                       23
<PAGE>

Item 2. Management's Discussion and Analysis

2.1 Results of Operations

Our revenues  totaled $114,266 and $108,177 for the three months ended September
30, 2004 and 2003,  respectively,  an increase of $6,089 (6%) in 2004, primarily
due to changing the company's sales focus to the services business.  Revenues in
the previous  period resulted  primarily from sales of equipment,  aperture card
media, and maintenance  services.  Revenues in this period included $60,885 from
the new services business.

For the three  months  ended  September  30,  2004 and  2003,  cost of sales was
$84,481 and $52,910,  respectively,  an increase of $31,571  (60%) in 2004.  The
cost of  sales  for  the  previous  period  consisted  primarily  of  labor  and
production  costs.  The cost of sales for this  period  consisted  primarily  of
labor, facility and equipment lease costs.

Operating expenses totaled $1,202,109 for the three month period ended September
30, 2004 as compared to $165,898 for the three month period ended  September 30,
2003, a $1,036,211 (625%) increase in 2004, primarily due to a increase in sales
related expenses and stock-based  compensation  for consulting  services accrued
over the past 18 months.

During the three months ended  September  30, 2004, we billed on 3 contracts for
document services, (19) maintenance contracts,  (1) network upgrades, and 18,000
aperture cards.

2.2 Liquidity and capital resources

We have historically  financed operations from the issuance of debt, the sale of
common stock and the conversion of common stock warrants. On September 30, 2004,
we had cash on hand of $11,670 and working  capital of $(854,163) as compared to
cash on hand of $15,600 and working  capital of  ($2,127,979)  at  period-ending
June 30, 2003.

Net cash used in operating  activities of  $(571,727)  and $552 for three months
ended September 30, 2004 and 2003,  respectively,  is attributed primarily to an
increase in stock-based compensation,  issuance of stock for consulting services
and accounts payable and accrued expenses.


Net  cash  used  for  investing  activities  of $0 for the  three  months  ended
September 30, 2004 and ($9,092) for the three months ended September 30, 2003 is
primarily related to no purchases of other assets made during the period.

Net cash provided by financing activities of $567,797 for the three months ended
September 30, 2004 is based  primarily on sale of securities.  Net cash provided
by financing  activities  of $(8,066) for the three months ended  September  30,
2003 is based  primarily on proceeds from  factoring  offset by notes payable to
stockholders.

We assumed  certain  payroll  tax  liabilities  as the result of the merger with
Pacific Diagnostic Technologies, Inc., on January 14, 1999. We have negotiated a
payment plan with the Internal  Revenue Service to pay the payroll taxes assumed
in the merger.

We believe that the receipt of net proceeds from the issuance of debt,  the sale
of the  common  stock  and the  exercise  of  common  stock  warrants  plus cash
generated  internally  from  sales  will be  sufficient  to  satisfy  our future
operations, working capital and other cash requirements for the remainder of the
fiscal year.  However, if we are unable to raise sufficient capital, we may need
to sell certain assets,  enter into new strategic  partnerships,  reorganize the
Company, or merge with another company to effectively maintain  operations.  Our
audit for the years  ended  June 30,  2004 and 2003  contained  a going  concern
qualification.
                                       24
<PAGE>

Item 3. Controls and Procedures

Our Chief  Executive  Officer and Chief  Financial  Officer  (collectively,  the
"Certifying   Officers")  are  responsible  for   establishing  and  maintaining
disclosure controls and procedures for the Company. Such officers have concluded
(based on their  evaluation of these controls and procedures as of a date within
90 days of the filing of this report) that the Company's disclosure controls and
procedures are effective to ensure that information  required to be disclosed by
the Company in this report is  accumulated  and  communicated  to the  Company's
management,  including its principal executive officers as appropriate, to allow
timely decisions  regarding required  disclosure.  The Certifying  Officers also
have indicated that there were no significant  changes in the Company's internal
controls  or  other  factors  that  could  significantly  affect  such  controls
subsequent to the date of their evaluation, and there were no corrective actions
with regard to significant deficiencies and material weaknesses.

                          PART II -- OTHER INFORMATION

Item 1. Legal Proceedings

On April 16, 2004, Decision One Corporation filed suit in the County of Bannock,
Idaho against us for $22,661.56  for goods  provided.  Since 2000,  Decision One
(formerly Imation) has been both a vendor to Quintek and a reseller of Quintek's
Q4300  Printers.  Quintek filed a counterclaim on August 1, 2004. We assert that
Decision One used its  authority as a dealer of our product to disparage  us, in
violation of its dealer  agreement  with us, and we seek relief for the hundreds
of thousands of dollars in business lost because of it.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.


On September  30, 2004,  Quintek  sold  14,000,000  shares of common stock to an
institutional investor at $0.139 per share.

On July 15, 2004,  Quintek  granted  300,000 of common stock to a consultant  in
consideration of services performed pursuant to a consulting agreement.

On July 27, Quintek sold a one year $50,000 convertible  promissory note bearing
ten percent annual interest to an accredited investor. On August 30,the note was
converted  into  500,000  shares of common  stock at  $0.10.  Additionally,  the
investor was granted, for each share converted pursuant to the note, one warrant
to purchase a share of common stock at $0.15 expiring 7/27/07.

On September  15,  2004,  Quintek  sold  1,000,000  shares of common stock to an
investor in consideration of $100,000;  additionally, the investor was granted a
three year warrant to purchase 1,000,000 of common stock at an exercise price of
$0.14.

On  August  5,  2004,  Quintek  sold  1,000,000  shares  of  common  stock to an
accredited investor in consideration of $70,000.

On August 5, 2004,  Quintek sold 500,000 shares of common stock to an accredited
investor in consideration of $35,000.

On August 26, 2004,  Quintek  granted 150,000 of common stock to a consultant in
consideration of services performed pursuant to a consulting agreement.

On July 1, Quintek sold a one year $20,000  convertible  promissory note bearing
ten percent annual  interest to an accredited  investor.  On August 30, the note
converted  into  200,000  shares of common  stock at  $0.10.  Additionally,  the
investor was granted, for each share converted pursuant to the note, one warrant
to purchase a share of common stock at $0.15 expiring 7/11/07.

                                       25
<PAGE>
On July 17, Quintek sold a one year $100,000 convertible promissory note bearing
ten percent annual interest to an accredited  investor.  The note is convertible
into 1,000,000 shares of common stock at $0.10.  Additionally,  the investor was
granted,  for each share converted pursuant to the note, one warrant to purchase
a share of common stock at $0.15 expiring 7/11/07.

On August 2, 2004, Quintek sold a two year $325,000 convertible  promissory note
bearing 5.75% annual interest to an accredited investor. The note is convertible
into shares of common stock.  The "Conversion  Price" of the note shall be equal
to the lesser of (i) $0.50,  or (ii) 80% of the  average of the 5 lowest  volume
weighted average prices during the 20 trading days prior to holder's election to
convert,  or (iii) 80% of the volume  weighted  average price on the trading day
prior to holder's election to;  additionally  Quintek granted 3,000,000 warrants
to purchase  common stock for a period of three years at $1.00.  Upon conversion
of the  note,  the  fund is  obligated  to  simultaneously  exercise  the  $1.00
warrants. The warrants must be exercised concurrently with the conversion of the
note in an amount equal to ten times the dollar amount of the note conversion.

On  September  29, 2004,  Quintek  granted  700,000  shares of common stock to a
consultant  in  consideration  of services  performed  pursuant to a  consulting
agreement.

On August  14,  2004,  Quintek  granted  302,271  shares  of  common  stock to a
consultant  in  consideration  of services  performed  pursuant to a  consulting
agreement.

On  September  26, 2004,  Quintek  granted  230,275  shares of common stock to a
consultant  in  consideration  of services  performed  pursuant to a  consulting
agreement.

On September  27, 2004,  Quintek  granted  648,256  shares of Series B Preferred
Stock to three creditors in consideration of conversion of $162,063.88 in debt.

On September  27, 2004,  Quintek  granted  724,077  shares of Series A Preferred
Stock in consideration of conversion of $36,203.84 in debt.

On September 27, 2004, Quintek granted 18,981 shares of Series C Preferred Stock
to eleven creditors in consideration of conversion of $18,981.16 in debt.

On September 27, 2004, Quintek granted 1,006,854 shares of Series A Preferred to
five employees in consideration of conversion of $251,713.50 in debt.

Subsequent Events

On October 1, Quintek  granted 175,000 shares of Common Stock to a consultant in
consideration of services performed pursuant to a consulting agreement.

On October 4, 2004,  Quintek sold 250,000  shares of common stock to an investor
in consideration of $25,000; additionally, the investor was granted a three year
warrant to purchase 250,000 of common stock at an exercise price of $0.15.

On October 16, 2004,  Quintek sold a six month $250,000  promissory note bearing
5.75  percent   annual   interest  to  an  accredited   investor  for  $250,000.
Additionally,  the investor was granted a 5,000,000  warrant to purchase  common
stock at $0.10 expiring 10/16/07.

Unless  otherwise  noted,  the sales set forth above  involved no  underwriter's
discounts or commissions and are claimed to be exempt from registration with the
Securities and Exchange  Commission  pursuant to Section 4 (2) of the Securities
Act of 1933,  as amended,  as  transactions  by an issuer not involving a public
offering,  the issuance and sale by the Company of shares of its common stock to
financially  sophisticated  individuals  who are  fully  aware of the  Company's
activities,  as well as its business and financial  condition,  and who acquired
said  securities for investment  purposes and  understood the  ramifications  of
same.
                                       26
<PAGE>

Item 3. Defaults Upon Senior Securities

N/A


Item 4. Submission of Matters to a Vote of Security Holders

During the three  month  period  ending  September  30,  2004,  no matters  were
submitted to a vote of security holders.

Item 5. Other Information

N/A


Item 6. Exhibits

(a) Exhibits

31.1  Certification  pursuant to Rule 13a-14 of the Securities  Exchange Act, as
adopted pursuant to Section 302 of the  Sarbanes-Oxley Act of 2002, of the Chief
Executive Officer

31.2  Certification  pursuant to Rule 13a-14 of the Securities  Exchange Act, as
adopted pursuant to Section 302 of the  Sarbanes-Oxley Act of 2002, of the Chief
Financial Officer

32.1  Certification  pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, of the Chief Executive Officer

32.2  Certification  pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, of the Chief Financial Officer


                                       27
<PAGE>


Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

                           QUINTEK TECHNOLOGIES, INC.





Date: November 10, 2004             /s/ ROBERT STEELE
                                    --------------------------------------------
                                    Robert Steele, Chairman
                                    and Chief Executive Officer

Date: November 10, 2004             /s/ ANDREW HAAG
                                    --------------------------------------------
                                    Andrew Haag, Chief Financial Officer




                                       28